Giuseppe Femia

Dr. Giuseppe Femia


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2022 in Clinical Medicine Insights: Cardiology
Verified
Journal Article
Open access
PDF file
JAJoseph Assad
Joseph Assad
GFGiuseppe Femia
Giuseppe Femia
PPPatrick Pender
Patrick Pender
TBTamer Badie
Tamer Badie
RRRohan Rajaratnam
Rohan Rajaratnam
Takotsubo Syndrome (TTS) is a condition of transient left ventricular dysfunction that is typically triggered by emotional or physical stress. Since first described in Japan in 1990, it has increasingly been recognised in clinical practice, accounting for up to 2% of Acute Coronary Syndrome (ACS) presentations. In fact, the clinical presentation can be indistinguishable from a myocardial infarction. Although current evidence suggests a catecholamine induced myocardial stunning, the pathophysiological mechanisms remain unknown. Interestingly, it is more common in woman, particularly those who are post-menopausal. This review aims to summarise the current research and provide an overview of the diagnostic strategies and treatment options.

22 December 2021 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
GFGiuseppe Femia
Giuseppe Femia
JFJohn K French
John K French
CJCraig Juergens
Craig Juergens
DLDominic Leung
Dominic Leung
SLSidney Lo
Sidney Lo
Right ventricular myocardial infarction (RVMI) and right ventricular (RV) failure are complications from an acute occlusion of a dominant right coronary artery (RCA) or left anterior descending (LAD) artery. Although some patients have good long-term RV recovery, RVMI is associated with high rates of in-hospital morbidity and mortality driven by hemodynamic compromise, cardiogenic shock, and electrical complications. As such, it is important to identify specific clinical signs and symptoms, initiate resuscitation and commence reperfusion therapy with fibrinolytic therapy or percutaneous coronary intervention. This review will discuss RVMI pathophysiology, describe the current diagnostic measures, highlight current therapies, and explore future management options.

24 April 2012 in Asia-Pacific Journal of Clinical Oncology
Verified
Journal Article
Open access
PDF file
GFGiuseppe Femia
Giuseppe Femia
THTodd A. Hardy
Todd A. Hardy
JSJudith M Spies
Judith M Spies
LHLisa G. Horvath
Lisa G. Horvath
Posterior reversible encephalopathy syndrome (PRES) is a neuro‐radiological syndrome characterized by seizures, altered level of consciousness and visual disturbance. PRES is associated with hyperintense lesions on magnetic resonance imaging (MRI) most commonly seen in the posterior regions. In most cases symptoms and radiological lesions are reversible. The aims of this article are: (i) to review the literature for all cases involving oxaliplatin, fluoropyrimidine and bevacizumab and (ii) highlight the increasing number of cases attributed to anti‐neoplastic agents. An in‐depth literature review was conducted by utilizing Pubmed's MEDLINE and Google Scholar databases. We found that there have been nine cases of PRES associated with oxaliplatin or fluoropyrimidine therapy; five cases also involved therapy with bevacizumab. Eight of the nine patients made a full recovery with a complete resolution of MRI changes. This is the first Australian case of PRES following treatment with oxaliplatin and a fluoropyrimidine and only the second case reported in which the patient did not recover despite appropriate medical management. It appears that PRES maybe more commonly associated with multi‐agent therapies and although reversible in most cases, PRES may result in adverse outcomes despite rapid intervention.

19 January 2021 in Forensic Science, Medicine and Pathology
Verified
Journal Article
Closed access
PDF file
GFGiuseppe Femia
Giuseppe Femia
NLNeil Langlois
Neil Langlois
JRJim Raleigh
Jim Raleigh
BGBelinda Gray
Belinda Gray
FOFarrah Othman
Farrah Othman
RPRajesh Puranik
Rajesh Puranik

1 January 2019 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
GFGiuseppe Femia
Giuseppe Femia
CSChristopher Semsarian
Christopher Semsarian
NLNeil Langlois
Neil Langlois
MMMark McGuire
Mark McGuire
JRJames Raleigh
James Raleigh
RPRajesh Puranik
Rajesh Puranik

1 April 2021 in International Journal of Cardiology
Verified
Journal Article
Closed access
GFGiuseppe Femia
Giuseppe Femia
DZDanyi Zhu
Danyi Zhu
PCPreeti Choudhary
Preeti Choudhary
SRSamantha B. Ross
Samantha B. Ross
VMVivek Muthurangu
Vivek Muthurangu
RPRajesh Puranik
Rajesh Puranik